Doctor profile · Federal record
Dr. Amin Esfahani, M.D.
Dermatology Physician (CMS: Dermatology) · Oakdale, CA
- NPI 1407261217
- Accepts Medicare
- MIPS 95.3 / 100 · 2023
- 12 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
1390 W H St Ste A
Oakdale, CA 953613529
(209) 755-7546
fax (209) 444-6634 - Additional location
-
1325 Melrose Ave Ste C
Modesto, CA 953505581 - Mailing address
-
2801 Grewal Pkwy Apt 533
Modesto, CA 953568018
Credentials & registration
- NPI registered
- July 2014 — 12 yrs on file
- Profile last updated
- December 16, 2024
- Year of graduation
- 2014 — 12 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- California #A172964
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1407261217. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
8,241
Distinct HCPCS
10
Medicare allowed
$505,586
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 4,040 | 479 | $7 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 1,123 | 644 | $94 | |
17000 |
Destruction of precancer skin growth, 1 growth | 919 | 564 | $58 | |
11102 |
Biopsy of related skin growth, first growth | 390 | 330 | $105 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 274 | 274 | $116 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 209 | 121 | $133 | |
17110 |
Destruction of skin growth, 1-14 growths | 188 | 141 | $121 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 131 | 92 | $179 | |
11103 |
Biopsy of related skin growth, each additional growth | 127 | 92 | $54 | |
11602 |
Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 102 | 94 | $129 |
In context: peer comparison
Among 1 peers in Oakdale Dermatology Physician, average services per provider: 284. This provider delivers 29× the peer median.Open Payments
Industry payments received
All-time total
$1,038
Transactions
40
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, INC. | 9 | $329.08 | |
| Abbvie INC. | 15 | $245.39 | |
| Incyte Corporation | 5 | $167.64 | |
| Regeneron Healthcare Solutions, INC. | 1 | $85.32 | |
| Lilly USA, LLC | 2 | $45.72 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $45.27 | |
| Leo Pharma INC. | 1 | $25.04 | |
| Organogenesis INC. | 1 | $22.23 | |
| Dermavant Sciences, INC. | 1 | $22.22 | |
| Teva Pharmaceuticals USA, INC. | 1 | $18.74 | |
| Ucb, INC. | 1 | $16.61 | |
| Arcutis Biotherapeutics, INC. | 1 | $14.29 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
942
Patients
620
Total drug cost
$33,044
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 186 | 102 | $4,006 |
| Triamcinolone Acetonide | Generic | 109 | 82 | $1,046 |
| Betamethasone Dipropionate | Generic | 108 | 67 | $6,499 |
| Mometasone Furoate | Generic | 92 | 72 | $2,701 |
| Mupirocin | Generic | 81 | 66 | $982 |
| Doxycycline Monohydrate | Generic | 59 | 52 | $1,502 |
| Clobetasol Propionate | Generic | 58 | 39 | $3,952 |
| Nystatin | Generic | 55 | 30 | $948 |
| Econazole Nitrate | Generic | 45 | 22 | $2,682 |
| Metronidazole | Generic | 34 | 23 | $2,657 |
Frequently asked questions
What is Dr. Amin Esfahani's medical specialty?
Dr. Amin Esfahani practices Dermatology Physician in Oakdale, CA.
Where does Dr. Amin Esfahani practice?
Dr. Amin Esfahani practices at 1390 W H St Ste A, Oakdale, CA 953613529. Office phone: 2097557546.
What is Dr. Amin Esfahani's NPI?
Dr. Amin Esfahani's National Provider Identifier (NPI) is 1407261217, issued by NPPES.
Does Dr. Amin Esfahani accept Medicare assignment?
Yes. Dr. Amin Esfahani accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Amin Esfahani commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.